跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mydoce - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mydoce
Approved
STANDARD
Mydoce
Mylan Laboratories Limited - OTL
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
46b1ce07a05accdd
Company
Mylan Laboratories Limited - OTL
Type
Standard
Approval Details
Approval Id
46b1ce07a05accdd
Drug Approval Philippines Name
Mydoce
Product Name
Mydoce
Registration Number
DR-XY47686
Brand Name
Mydoce
Generic Name
Docetaxel
Dosage Form
Concentrate Solution for IV Infusion : Antineoplastic
Dosage Strength
10mg/mL
Manufacturer
Mylan Laboratories Limited - OTL
Importer
Mylan Philippines Inc.
Distributor
Mylan Philippines Inc.
Company Detail Path
/organization/mylan-laboratories-limited
Issuance Date
25 January 2022
Expiry Date
25 January 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
46b1ce07a05accdd
Type
Standard
Back to Philippines FDA Approvals